Pharmacogenomics of cantharidin in tumor cells
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- Onat Kadioglu
- Navid Salehi Kermani
- Gerhard Kelter
- Udo Schumacher
- Heinz-Herbert Fiebig
- Henry Johannes Greten
- Thomas Efferth
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000330499200003&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.bcp.2013.10.025
- eISSN
- 1873-2968
- Externe Identifier
- Clarivate Analytics Document Solution ID: 300YF
- PubMed Identifier: 24231507
- ISSN
- 0006-2952
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- BIOCHEMICAL PHARMACOLOGY
- Schlüsselwörter
- Blister beetle
- Cancer
- Cantharidin
- Microarray
- Protein phosphatase
- Paginierung
- 399 - 409
- Datum der Veröffentlichung
- 2014
- Status
- Published
- Titel
- Pharmacogenomics of cantharidin in tumor cells
- Sub types
- Article
- Ausgabe der Zeitschrift
- 87
Data source: Web of Science (Lite)
- Other metadata sources:
-
- Autoren
- Onat Kadioglu
- Navid Salehi Kermani
- Gerhard Kelter
- Udo Schumacher
- Heinz-Herbert Fiebig
- Henry Johannes Greten
- Thomas Efferth
- DOI
- 10.1016/j.bcp.2013.10.025
- ISSN
- 0006-2952
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Biochemical Pharmacology
- Sprache
- en
- Paginierung
- 399 - 409
- Datum der Veröffentlichung
- 2014
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.bcp.2013.10.025
- Datum der Datenerfassung
- 2019
- Titel
- Pharmacogenomics of cantharidin in tumor cells
- Ausgabe der Zeitschrift
- 87
Data source: Crossref
- Abstract
- Cantharis vesicatoria (blister beetle) is used in Chinese medicine and has been categorized as highly toxic in the Chinese pharmacopeia. In Europe, Cantharis patches have been used since ages to treat various skin-related diseases. We investigated the cytotoxicity of the Cantharis ingredient, cantharidin, in 41 tumor cell lines (Oncotest panel) and compared the results with those of 60 cell lines of the National Cancer Institute, USA. We found profound activity at low micromolar concentrations (log ₁₀IC₅₀ values between -6.980 and 5.009 M). Cantharidin bound to protein phosphatase 2A (PP2A) with higher affinity (-8.12 kcal/mol) than to PP1 (-6.25 kcal/mol) in molecular docking analyses. Using a PCR array for 84 apoptosis genes, cantharidin treatment upregulated gene expression of caspase-1 and nerve growth factor receptor, but downregulated mRNA expression of Bcl-2 like protein 10, Fas ligand, and tumor necrosis factor-α. By using COMPARE analysis of microarray-based transcriptome-wide mRNA expressions, 21 genes were found to significantly correlate with response of 60 tumor cell lines to cantharidin. As shown by hierarchical cluster analysis and chi-squared test, the distribution of cell lines in the dendrogram according to their gene expression profiles predicted sensitivity or resistance to cantharidin (P=6.482 × 10(-5)). The compassionate use of Cantharis patches in two patients suffering from basalioma and Mycosis fungoides, respectively, considerably improved the diseases without signs of toxicity. In conclusion, these results indicate that cantharidin may be a useful candidate to develop novel strategies for cancer therapy.
- Addresses
- Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.
- Autoren
- Onat Kadioglu
- Navid Salehi Kermani
- Gerhard Kelter
- Udo Schumacher
- Heinz-Herbert Fiebig
- Henry Johannes Greten
- Thomas Efferth
- Thomas Efferth
- DOI
- 10.1016/j.bcp.2013.10.025
- eISSN
- 1873-2968
- Externe Identifier
- PubMed Identifier: 24231507
- Open access
- false
- ISSN
- 0006-2952
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Biochemical pharmacology
- Schlüsselwörter
- Cell Line, Tumor
- Animals
- Humans
- Cantharidin
- Receptors, Neuropeptide Y
- RNA, Messenger
- Oligonucleotide Array Sequence Analysis
- Pharmacogenetics
- Gene Expression Regulation, Enzymologic
- Binding Sites
- Molecular Structure
- Protein Conformation
- Models, Molecular
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2013
- Paginierung
- 399 - 409
- Datum der Veröffentlichung
- 2014
- Status
- Published
- Datum der Datenerfassung
- 2013
- Titel
- Pharmacogenomics of cantharidin in tumor cells.
- Sub types
- Journal Article
- Ausgabe der Zeitschrift
- 87
Data source: Europe PubMed Central
- Abstract
- Cantharis vesicatoria (blister beetle) is used in Chinese medicine and has been categorized as highly toxic in the Chinese pharmacopeia. In Europe, Cantharis patches have been used since ages to treat various skin-related diseases. We investigated the cytotoxicity of the Cantharis ingredient, cantharidin, in 41 tumor cell lines (Oncotest panel) and compared the results with those of 60 cell lines of the National Cancer Institute, USA. We found profound activity at low micromolar concentrations (log ₁₀IC₅₀ values between -6.980 and 5.009 M). Cantharidin bound to protein phosphatase 2A (PP2A) with higher affinity (-8.12 kcal/mol) than to PP1 (-6.25 kcal/mol) in molecular docking analyses. Using a PCR array for 84 apoptosis genes, cantharidin treatment upregulated gene expression of caspase-1 and nerve growth factor receptor, but downregulated mRNA expression of Bcl-2 like protein 10, Fas ligand, and tumor necrosis factor-α. By using COMPARE analysis of microarray-based transcriptome-wide mRNA expressions, 21 genes were found to significantly correlate with response of 60 tumor cell lines to cantharidin. As shown by hierarchical cluster analysis and chi-squared test, the distribution of cell lines in the dendrogram according to their gene expression profiles predicted sensitivity or resistance to cantharidin (P=6.482 × 10(-5)). The compassionate use of Cantharis patches in two patients suffering from basalioma and Mycosis fungoides, respectively, considerably improved the diseases without signs of toxicity. In conclusion, these results indicate that cantharidin may be a useful candidate to develop novel strategies for cancer therapy.
- Date of acceptance
- 2013
- Autoren
- Onat Kadioglu
- Navid Salehi Kermani
- Gerhard Kelter
- Udo Schumacher
- Heinz-Herbert Fiebig
- Henry Johannes Greten
- Thomas Efferth
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/24231507
- DOI
- 10.1016/j.bcp.2013.10.025
- eISSN
- 1873-2968
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Biochem Pharmacol
- Schlüsselwörter
- Blister beetle
- Cancer
- Cantharidin
- Microarray
- Protein phosphatase
- Animals
- Binding Sites
- Cantharidin
- Cell Line, Tumor
- Gene Expression Regulation, Enzymologic
- Humans
- Models, Molecular
- Molecular Structure
- Oligonucleotide Array Sequence Analysis
- Pharmacogenetics
- Protein Conformation
- RNA, Messenger
- Receptors, Neuropeptide Y
- Sprache
- eng
- Country
- England
- Paginierung
- 399 - 409
- PII
- S0006-2952(13)00709-0
- Datum der Veröffentlichung
- 2014
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2014
- Titel
- Pharmacogenomics of cantharidin in tumor cells.
- Sub types
- Journal Article
- Ausgabe der Zeitschrift
- 87
Data source: PubMed
- Beziehungen:
- Property of